ZD4054 (Zibotentan) or Placebo Plus Chemotherapy in Patients With Advanced Ovarian Cancer

Clinical trial NCT00929162 · TERMINATED

Trial details

NCT number: NCT00929162
Sponsor: AstraZeneca
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Patients With Advanced Ovarian Cancer Sensitive to Platinum-based Chemotherapy

Start date: 2009-06-01
Primary completion: 2011-06-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.